We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-Rs 100 crore acquisition market, sized. Read it →
Home/ Cases/ Pharmaceuticals/ India Pencillins Limited
✓ RESOLVED — PLAN APPROVED ● STILL OPERATING · MCA ACTIVE

India Pencillins Limited

Corporate insolvency resolution — resolution plan approved · May 2020

Metals & chemicals manufacturer · public limited company · incorporated 1992 · 27 years old at admission

Sector Pharmaceuticals Bench NCLT Hyderabad CIN U24230TG1992PLC014774 Admitted 05 Nov 2019 Initiated by OC
Acquired by
Mac Labs Limited
Named in the NCLT plan-approval order dated 29 May 2020, reproduced as printed in that order. · read the order

Case record

the public record -- figures open below

Corporate insolvency record of India Pencillins Limited, commenced 05 Nov 2019, at NCLT Hyderabad, initiated by OC. Current status: Resolved. The matter concluded 29 May 2020.

CIN
U24230TG1992PLC014774
Incorporated
1992
Registered State
Telangana
NCLT Bench
Hyderabad
Initiated by
OC
Commencement
05 Nov 2019
Outcome Date
29 May 2020
Sector
Pharmaceuticals
Resolution Professional
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

Admitted claims Recovery waterfall & haircut Sector benchmarks Case timeline & professionals Committee of creditors Plan value & CoC vote Intelligence note
See plans →
Just this company — Rs 1,999 · apply for access →

One company, bought outright — yours permanently, including future updates. Subscribe within 30 days and the whole Rs 1,999 comes off your first month, so starting with one case costs nothing against subscribing later.

Questions? WhatsApp us →
Other Pharmaceuticals cases
Kudos Chemie Limited
Resolved
Parabolic Drugs Limited
Resolved
Kandla Energy and Chemicals Limited
Liquidation
Apex Drugs Ltd.
Resolved
Sources, basis and disclaimers → ·
report an error